Questions a plan sponsor actually asks.
What is Tremelimumab used for?
Tremelimumab is a CTLA-4-directed Blocking Antibody medication tracked in Medicare Part D.
Is there a generic for Tremelimumab?
No. Tremelimumab is brand-only with no generic equivalents currently in market.
How much does my plan pay for Tremelimumab?
NADAC pricing data not currently available for this drug.
Is Tremelimumab on the FDA shortage list?
No. Tremelimumab is not currently on the FDA Drug Shortage Database.
5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.